A detailed history of Barclays PLC transactions in Illumina, Inc. stock. As of the latest transaction made, Barclays PLC holds 215,380 shares of ILMN stock, worth $29.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
215,380
Previous 215,380 -0.0%
Holding current value
$29.4 Million
Previous $28.1 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$105.28 - $135.9 $10.5 Million - $13.5 Million
-99,688 Reduced 31.64%
215,380 $28.1 Million
Q2 2024

Aug 14, 2024

SELL
$101.05 - $133.57 $46.5 Million - $61.5 Million
-460,348 Reduced 59.37%
315,068 $32.9 Million
Q1 2024

May 15, 2024

SELL
$127.73 - $147.2 $35.4 Million - $40.8 Million
-276,941 Reduced 26.32%
775,416 $106 Million
Q4 2023

Feb 15, 2024

SELL
$92.79 - $142.53 $66.4 Million - $102 Million
-715,998 Reduced 40.49%
1,052,357 $147 Million
Q3 2023

Nov 07, 2023

BUY
$128.91 - $192.44 $124 Million - $186 Million
964,709 Added 120.04%
1,768,355 $243 Million
Q2 2023

Aug 03, 2023

BUY
$183.43 - $232.67 $107 Million - $136 Million
583,981 Added 265.85%
803,646 $151 Million
Q1 2023

May 04, 2023

SELL
$193.75 - $232.55 $1.47 Million - $1.76 Million
-7,585 Reduced 3.34%
219,665 $51.1 Million
Q4 2022

Feb 13, 2023

BUY
$187.24 - $242.74 $8.84 Million - $11.5 Million
47,199 Added 26.21%
227,250 $45.9 Million
Q3 2022

Nov 03, 2022

SELL
$177.23 - $227.44 $5.52 Million - $7.09 Million
-31,157 Reduced 14.75%
180,051 $34.4 Million
Q2 2022

Aug 12, 2022

SELL
$181.58 - $368.0 $5.87 Million - $11.9 Million
-32,327 Reduced 13.27%
211,208 $38.9 Million
Q1 2022

May 16, 2022

SELL
$303.87 - $423.8 $30.8 Million - $42.9 Million
-101,324 Reduced 29.38%
243,535 $85.1 Million
Q4 2021

Feb 14, 2022

BUY
$347.28 - $421.83 $1.84 Million - $2.24 Million
5,305 Added 1.56%
344,859 $131 Million
Q3 2021

Nov 09, 2021

BUY
$405.61 - $524.84 $43.6 Million - $56.4 Million
107,447 Added 46.29%
339,554 $138 Million
Q2 2021

Aug 13, 2021

SELL
$372.84 - $481.5 $1.26 Million - $1.63 Million
-3,392 Reduced 1.44%
232,107 $110 Million
Q1 2021

May 13, 2021

BUY
$361.28 - $504.76 $24.7 Million - $34.5 Million
68,282 Added 40.83%
235,499 $90.4 Million
Q4 2020

Feb 11, 2021

BUY
$292.7 - $370.96 $8.63 Million - $10.9 Million
29,492 Added 21.41%
167,217 $61.9 Million
Q3 2020

Nov 12, 2020

BUY
$268.51 - $400.74 $3.1 Million - $4.62 Million
11,533 Added 9.14%
137,725 $42.6 Million
Q2 2020

Aug 12, 2020

SELL
$256.46 - $373.01 $6.34 Million - $9.22 Million
-24,728 Reduced 16.38%
126,192 $46.7 Million
Q1 2020

May 13, 2020

SELL
$209.2 - $335.53 $40.5 Million - $65 Million
-193,691 Reduced 56.21%
150,920 $41.2 Million
Q4 2019

Feb 10, 2020

SELL
$288.29 - $335.49 $17.6 Million - $20.5 Million
-61,090 Reduced 15.06%
344,611 $114 Million
Q3 2019

Nov 14, 2019

BUY
$266.84 - $378.23 $47.5 Million - $67.3 Million
178,042 Added 78.21%
405,701 $123 Million
Q2 2019

Aug 14, 2019

BUY
$300.59 - $368.15 $15.8 Million - $19.4 Million
52,594 Added 30.04%
227,659 $83.8 Million
Q1 2019

May 15, 2019

SELL
$272.57 - $321.18 $5.79 Million - $6.82 Million
-21,226 Reduced 10.81%
175,065 $54.4 Million
Q4 2018

Feb 14, 2019

SELL
$272.46 - $366.54 $18.7 Million - $25.2 Million
-68,744 Reduced 25.94%
196,291 $58.9 Million
Q3 2018

Nov 14, 2018

BUY
$279.04 - $367.06 $10.9 Million - $14.3 Million
39,065 Added 17.29%
265,035 $97.3 Million
Q2 2018

Aug 14, 2018

SELL
$228.17 - $292.07 $18.8 Million - $24.1 Million
-82,512 Reduced 26.75%
225,970 $63.1 Million
Q1 2018

May 15, 2018

BUY
$209.54 - $253.91 $19.3 Million - $23.3 Million
91,949 Added 42.46%
308,482 $72.9 Million
Q4 2017

Feb 14, 2018

BUY
$202.23 - $230.03 $13.1 Million - $14.9 Million
64,878 Added 42.78%
216,533 $47.3 Million
Q3 2017

Nov 14, 2017

BUY
$172.3 - $213.93 $26.1 Million - $32.4 Million
151,655
151,655 $30.2 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.